Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

Brain Research Bulletin

Volumn 40, Issue 1, 1996, Pages 57-62

  Miller, David W ^a   Abercrombie, Elizabeth D ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

d Amphetamine; Dizocilpine maleate; Dopamine; Glutamate; Microdialysis MK 801; N methyl D aspartate receptors

Indexed keywords

DEXAMPHETAMINE; DIZOCILPINE; DOPAMINE; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030010055     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(95)02144-2     Document Type: Article

References (51)

1. Abercrombie, E. D.; Finlay, J. M. Monitoring extracellular norepinephrine in brain using in vivo microdialysis and HPLC-EC. In: Robinson, T. E.; Justice, J. B., Jr., eds. Microdialysis in the neurosciences. Amsterdam: Elsevier; 1991:253-274.
2. Arias-Montaño, J. A.; Martinez-Fong, D.; Aceves, J. Glutamate stimulation of tyrosine hydroxylase is mediated by NMDA receptors in the rat striatum. Brain Res. 569:317-322; 1992.
3. Bouyer, J. J.; Park, D. H.; Joh, T. H.; Pickel, V. M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302:267-275; 1984.
4. Bunney, B. S.; Aghajanian, G. K. d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway. Arch. Pharmacol. 304:255-261; 1978.
5. Butcher, S. P.; Fairbrother, I. S.; Kelly, J. S.; Arbuthnott, G. W. Amphetamine-induced dopamine release in the rat striatum: An in vivo microdialysis study. J. Neurochem. 50:346-355; 1988.
6. Carlsson, M.; Carlsson, A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:272-276; 1990.
7. Carter, C. J.; L'Heureux, R. L.; Scatton, B. Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: A trans-striatal dialysis study. J. Neurochem. 51:462-468; 1988.
8. Cheramy, A.; Romo, R.; Godheu, G.; Baruch, P.; Glowinski, J. In vivo presynaptic control of dopamine release in the cat caudate nucleus-II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience 19:1081-1090; 1986.
9. Clow, D. W.; Jhamandas, K. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J. Pharmacol. Exp. Ther. 248:722-728; 1989.
10. Commissiong, J. W. Monoamine metabolites: Their relationship and lack of relationship to monoaminergic neuronal activity. Biochem. Pharmacol. 34:1127-1131; 1985.
11. Desce, J. M.; Godeheu, G.; Galli, T.; Artaud, F.; Cheramy, A.; Glowinski, J. L-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: Involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience 47:333-339; 1992.
12. Fischer, J. F.; Cho, A. K. Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. 208:203-209; 1979.
13. French, E. D.; Ceci, A. Noncompetitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci. Lett. 119:159-162; 1990.
14. French, E. D.; Mura, A.; Wang, T. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists. Synapse 13:108-116; 1993.
15. Freund, T. F.; Powell, J. F.; Smith, A. D. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13:1189-1215; 1984.
16. Gandolfi, O.; Rimondini, R.; Dall'Olio, R. The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms. Neuropharmacology 31:1111-1114; 1992.
17. Giorguieff, M. F.; Kernel, M. L.; Glowinski, J. Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci. Lett. 6:73-77; 1977.
18. Heeringa, M. J.; Abercrombie, E. D. Biochemistry of somatodendritic dopamine release in substantia nigra: An in vivo comparison with striatal dopamine release. J. Neurochem. 65:192-200; 1995.
19. Hiramatsu, M.; Cho, A. K.; Nabeshima, T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur. J. Pharmacol. 166:359-366; 1989.
20. Imperato, A.; Scrocco, M. G.; Bacchi, S.; Angelucci, L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187:555-556; 1990.
21. Kashihara, K.; Hamamura, T.; Okumura, K.; Otsuki, S. Effect of MK-801 on endogenous dopamine release in vivo. Brain Res. 528:80-82; 1990.
22. Keefe, K. A.; Zigmond, M. J.; Abercrombie, E. D. Excitatory amino acid receptor involvement in the regulation of striatal extracellular dopamine. In: Kalsner, S.; Westfall, T. C., eds. Presynaptic receptors and the question of autoregulation of neurotransmitter release. Ann. NY Acad. Sci. 604:614-616; 1990.
23. Keefe, K. A.; Zigmond, M. J.; Abercrombie, E. D. Extracellular dopamine in striatum: Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 47:325-332; 1992.
24. Kim, J. S.; Kornhuber, H. H.; Schmid-Burgk, W.; Holzmuller, B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20:379-382; 1980.
25. Kiss, J. P.; Tóth, E.; Lajtha, A.; Vizi, E. S. NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: A microdialysis study. Brain Res. 641:145-148; 1994.
26. Klockgether, T.; Turski, L. Toward an understanding of the role of glutamate in experimental parkinsonism: Agonist-sensitive sites in the basal ganglia. Ann. Neurol. 34:585-593; 1993.
27. Koek, W.; Colpaert, F. C. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: Relationship with phencyclidine-like behavioral effects. J. Pharmacol. Exp. Ther. 252:349-357; 1990.
28. Koek, W.; Woods, J. H.; Winger, G. D. MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245:969-974; 1988.
29. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. Biochem. Pharmacol. 31:983-992; 1982.
30. Liljequist, S.; Ossowska, K.; Grabowska-Anden, M.; Anden, N. E. Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur. J. Pharmacol. 195:55-61; 1991.
31. ++-independent dopamine release from striatal slices: A possible role of reverse dopamine transport. J. Pharmacol. Exp. Ther. 256:1132-1138; 1991.
32. Löscher, W.; Annies, R.; Hönack, D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128:191-194; 1991.
33. Macciardi, F.; Lucca, A.; Catalano, M.; Marino, C.; Zanardi, R.; Smeraldi, E. Amino acid patterns in schizophrenia: Some new findings. Psychiatry Res. 32:63-70; 1990.
34. Moghaddam, B.; Gruen, R. J. Do endogenous excitatory amino acids influence striatal dopamine release? Brain Res. 544:329-330; 1991.
35. Moghaddam, B.; Gruen, R. J.; Roth, R. H.; Bunney, B. S.; Adams, R. N. Effect of L-glutamate on the release of striatal dopamine: In vivo dialysis and electrochemical studies. Brain Res. 518:55-60; 1990.
36. Moghaddam, B.; Schenk, J. O.; Stewart, W. B.; Hansen, A. J. Temporal relationship between neurotransmitter release and ion flux during spreading depression and anoxia. Can. J. Physiol. Pharmacol. 65:1105-1110; 1987.
37. Murase, S.; Mathé, J. M.; Grenhoff, J.; Svensson, T. H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: Differential actions on firing pattern related to anatomical localization. J. Neural Transm. Gen. Sect. 91:13-25; 1993.
38. Niddam, R.; Arbilla, S.; Scatton, B.; Dennis, T.; Langer, S. Z. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine. Arch. Pharmacol. 329:123-127; 1985.
39. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1986.
40. Rao, T. S.; Kim, H. S.; Lehmann, J.; Martin, L. L.; Wood, P. L. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: Regional studies in the rat. J. Neurochem. 54:1157-1162; 1990.
41. 3H]dopamine release from rat striatum: An in vitro model for glutamate actions. J. Neurochem. 32:1539-1545; 1979.
42. Segal, D. S.; Kuczenski, R.; Florin, S. M. Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? Behav. Neurosci. 109:532-546; 1995.
43. Sesack, S. R.; Pickel, V. M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320:145-160; 1992.
44. Shimizu, N.; Duan, S.; Hori, T.; Oomura, Y. Glutamate modulates dopamine release in the striatum as measured by brain microdialysis. Brain Res. Bull. 25:99-102; 1990.
45. Steinfels, G. F.; Tam, S. W.; Cook, L. Electrophysiological effects of selective σ-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Neuropsychopharmacology 2:201-208; 1989.
46. Tricklebank, M. D.; Singh, L.; Oles, R. J.; Preston, C.; Iversen, S. D. The behavioural effects of MK-801: A comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167:127-135; 1989.
47. Tschanz, J. T.; Griffith, K. E.; Haracz, J. L.; Rebec, G. V. Cortical lesions attenuate the opposing effects of amphetamine and haloperidol on neostriatal neurons in freely moving rats. Eur. J. Pharmacol. 257:161-167; 1994.
48. Weihmuller, F. B.; O'Dell, S. J.; Cole, B. N.; Marshall, J. F. MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: An in vivo microdialysis study. Brain Res. 549:230-235; 1991.
49. Whitton, P. S.; Biggs, C. S.; Pearce, B. R.; Fowler, L. J. Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci. Lett. 142:5-8; 1992.
50. Wong, E. H. F.; Kemp, J. A.; Priestley, T.; Knight, A. R.; Woodruff, G. N.; Iverson, L. L. The anticonvulsant MK-801 is a potent NMDA antagonist. Proc. Natl. Acad. Sci. USA 83:7104-7108; 1986.
51. Zhang, J.; Chiodo, L. A.; Freeman, A. S. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res. 590:153-163; 1992.